ArticleChina CDC weekly2022
Emergence of Autochthonous Melioidosis in Two Inland PLADs - China, 2021.
Article in China CDC weekly, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 2 citations in OpenAlex.
- Investigation of a Fatal Imported Case of Melioidosis - Jingmen City, Hubei Province, China, May 2026.China CDC weekly · 2026Article
- Phage-mediated control of melioidosis in Southern China: molecular insights and therapeutic potential of N4-like viruses from Hainan.BMC microbiology · 2025Article
- Dysfunctional host cellular immune responses are associated with mortality in melioidosis.Emerging microbes & infections · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known about this topic?: Melioidosis, a tropical infectious disease caused by What is added by this report?: Three melioidosis cases, including two in young children and one in a 19-year-old female, were reported in Anhui and Jiangxi (two inland PLADs of China) respectively, in 2021. None of the patients had a travel history to a melioidosis-endemic area. All the BP isolates belonged to the same sequence type (ST51), which had been reported from elsewhere in Southeast Asia. What are the implications for public health practice?: This is the first report of autochthonous melioidosis cases in inland Chinese PLADs. Surveillance and prevention and control work should be strengthened in this region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.